PET monitoring of cancer therapy with He-3 and C-12 beams: a study with the GEANT4 toolkit
We study the spatial distributions of β+-activity produced by therapeutic beams of 3He and 12C ions in various tissue-like materials. The calculations were performed within a Monte Carlo model for Heavy-Ion Therapy (MCHIT) based on the GEANT4 toolkit. The contributions from 10,11C, 13N, 14,15O, 17,18F and 30P positron-emitting nuclei were calculated and compared with experimental data obtained during and after irradiation. Positron emitting nuclei are created by 12C beam in fragmentation reactions of projectile and target nuclei. This leads to a β+-activity profile characterised by a noticeable peak located close to the Bragg peak in the corresponding depth-dose distribution. On the contrary, as the most of positron-emitting nuclei are produced by 3He beam in target fragmentation reactions, the calculated total β+-activity during or soon after the irradiation period is evenly distributed within the projectile range. However, we predict also the presence of 13N, 14O, 17,18F created in charge-transfer reactions by low-energy 3He ions close to the end of their range in several tissue-like media. The time evolution of β+-activity profiles was investigated for both kinds of beams. Due to the production of 18F nuclide the β+-activity profile measured 2 or 3 hours after irradiation with 3He ions will have a distinct peak correlated with the maximum of depth-dose distribution. We found certain advantages of low-energy 3He beams over low-energy proton beams for reliable PET monitoring during particle therapy of shallow located tumours. In this case the distal edge of β+-activity distribution from 17F nuclei clearly marks the range of 3He in tissues.
